plasminogen activator
plasminogen activator是什么意思、plasminogen activator怎么读
plasminogen activator 基本解释
网络 纤溶酶原激活物; 纤维蛋白溶酶原激活物; 纤溶酶原激活剂; 纤维蛋白溶酶原激活剂; 有胞浆素原激活因子
重点词汇
- activatorn. 活化剂, 催化剂, 触媒剂 [化] 助催化剂; 活化剂; 激活剂; 激活剂发光材料
- plasminogen[化] 纤溶酶原; 血纤维蛋白溶酶原
plasminogen activator 双语例句
- 1、
Comparison of Recombinant Tissue plasminogen activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较 - 2、
Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis
骨关节炎滑膜中尿激酶型纤溶酶原激活物及其受体蛋白的表达 - 3、
Changes of homeostatic activation in patients after percutaneous coronary intervention and its relationship with plasminogen activator inhibitor-1 gene polymorphism
冠脉介入治疗后止凝血功能的改变及其与PAI基因多态性的关系 - 4、
Objective To construct an expression vector for highly efficient expression of tissue-type plasminogen activator ( t-PA) confined in the mammary gland of cow to develop a cow mammary gland bioreactor.
目的构建组织型纤溶酶原激活剂(t-PA)乳腺定位表达载体,使其在牛乳汁中高效表达,从而建立牛乳腺生物反应器。 - 5、
Expression of Matrix Metalloproteinase-9 and Urokinase-type plasminogen activator and Their Relationship with the Invasiveness of WHO Grade ⅰ Meningioma
MMP-9和uPA的表达与WHOⅠ级脑膜瘤侵袭性的关系 - 6、
Comparison of thrombolytic therapy with recombinant tissue plasminogen activator and urokinase for acute myocardial infarction;
目的探讨静脉溶栓对男女急性心肌梗塞患者的疗效对比。 - 7、
Clinical Significance of Measurement of Plasma Urokinase Type plasminogen activator and its Receptor in Cancer Patients
癌症患者尿激酶型纤溶酶原激活物及其受体检测的临床意义 - 8、
Gene expression and significance of urokinase type plasminogen activator and its receptor in oral and maxillofacial tumor tissue
口腔颌面部恶性肿瘤尿激酶及其受体的基因表达和临床意义 - 9、
The Initial Research about the Effect of Tissue plasminogen activator on Neural Repair
组织纤溶酶原激活物对神经修复影响的初步探讨 - 10、
Inhibitory effect of green tea polyphenols on plasminogen activator inhibitor-1 expression Something that checks or restrains
绿茶多酚对纤溶酶原激活物抑制剂-1表达影响 - 11、
Clinical significance of the expression of urokinase type plasminogen activator system in endometrial carcinoma
子宫内膜腺癌组织中尿激酶型纤溶酶原激活系统的表达及其临床意义 - 12、
Inhibitory effects of spironolactone on expression of plasminogen activator inhibitor-1 induced by high glucose in rat glomerular mesangial cells
螺内酯对高糖诱导的大鼠肾小球系膜细胞PAI-1表达的抑制作用 - 13、
Relationship between plasminogen activator system and PCOS
纤溶酶原激活系统与多囊卵巢综合征的相关性研究 - 14、
Expression of plasminogen activator in human bladder cancer
纤溶酶原激活物在膀胱移行细胞癌中的表达及其意义 - 15、
Expressions of Survivin and uPA in human cerebral gliomas Comparison of Recombinant Tissue plasminogen activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
脑胶质瘤组织中Survivin和尿激酶型纤溶酶原激活物蛋白的表达重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较 - 16、
Intravenous Thrombolysis by Tissue-type plasminogen activator Deletion Mutant in a Rabbit Model of Retinal Artery Occlusion
两种组织型纤溶酶原激活剂缺失突变体(r-PA)治疗实验性兔视网膜动脉阻塞 - 17、
The relation of plasma plasminogen activator inhibitor activity and coronary heart disease Relationship between plasminogen activator inhibitor 1 and neuroblastoma
纤溶酶原激活抑制物活性与冠心病发病关系纤溶酶原激活物抑制物1与神经母细胞瘤 - 18、
Correlation among plasma plasminogen activator inhibitor one, lipid disorder and insulin resistance in gestational diabetes mellitus
血浆PAI-1与脂质紊乱、胰岛素抵抗及妊娠期糖尿病的相关性研究 - 19、
Growth movement of hepatic-stellate-cell-T6 cell line and secreting law of urokinase plasminogen activator
肝星状细胞-T6细胞系生长动态及分泌尿激酶型纤溶酶原激活物规律的研究 - 20、
Change of plasminogen activator inhibitor type-1 in the hippocampus of diabetic rats and effect of minocycline
糖尿病大鼠海马内PAI-1的变化及米诺环素对其的影响 - 21、
The high-phenol group also experienced a greater drop in the activity of another clot promoter, plasminogen activator inhibitor-1.
高酚早餐组另一血栓促进因子&纤维蛋白溶酶原活化抑制因子-1的活性也呈现显著降低。 - 22、
Expression of Polo-like Kinase ( PLK1) mRNA in Pterygium; Relationship between plasminogen activator inhibitor 1 and neuroblastoma
保罗样激酶1mRNA在翼状胬肉中的表达纤溶酶原激活物抑制物1与神经母细胞瘤 - 23、
Lysis of the hematoma with various enzymes, such as urokinase or tissue plasminogen activator ( TPA), and drainage of liquefied clot has become an alternative.
因而,应用不同的酶如尿激酶或组织纤维蛋白溶酶原激活剂来溶解血肿和引流液化的血凝块,成为可供选择的治疗方法。 - 24、
Effect of Arotinolol on High-sensitive C-reactive Protein and plasminogen activator Inhibitor-1 in Patients with Unstable Angina
阿罗洛尔对不稳定型心绞痛患者高敏C反应蛋白和纤溶酶原激活物抑制剂-1含量的影响 - 25、
A Case of Deficiency of Plasma plasminogen activator Inhibitor 1, Its Diagnosis, Treatment and Study on Molecular Abnormality
遗传性纤溶酶原激活剂抑制物-1缺乏症的诊断、治疗及发病机理的研究 - 26、
Relationship between the Changes of Activity of Tissue-Type plasminogen activator on Brains and Cerebral Edema in Asphyxia Status of Mice
窒息鼠脑组织型纤溶酶原激活物活性变化与脑水肿的关系 - 27、
Effects of interleukin-1 β and interleukin-1 receptor antagonist on the expression of urokinase-type plasminogen activator in colon carcinoma cells
IL-1β及IL-1ra对结肠癌细胞表达uPA的影响 - 28、
Co-transfection of small interfering RNA to PDGF-B mRNA and tissue-type plasminogen activator gene prevents rabbit experimental restenosis
纳米tPA基因和PDGF-B小干扰RNA预防兔实验性再狭窄 - 29、
Effects of Thrombin-activable Fibrinolysis Inhibitor and Hirudin on Fibrinolysis; Relationship between plasminogen activator inhibitor 1 and neuroblastoma
凝血酶激活的纤溶抑制剂与水蛭素对纤溶的影响纤溶酶原激活物抑制物1与神经母细胞瘤
plasminogen activator 英英释义
noun

